13 November 2017 - 17 November 2017
Messe Düsseldorf, Germany
Abingdon Health will once again be visiting Medica to showcase our lateral flow assay and reader development and manufacturing capabilities, as well as our rapid diagnostic products such as Seralite®– FLC* and PCRD (NALFIA).
Abingdon Health provides lateral flow assay development and manufacturing in ISO13485 certified and GMP compliant facilities. We also offer lateral flow reader OEM using our FDA cleared ADxLR5® lateral flow reader.
The Seralite® Product Range includes both lateral flow and ELISA technology and is designed to aid in the diagnosis and monitoring of patients with Multiple Myeloma.
Our nucleic acid lateral flow immunoassay, PCRD, is used as an alternative to using DNA agarose gel electrophoresis.
To arrange a meeting with our team at Medica 2017 please email email@example.com or +44 (0) 1904 406080.*Not available for sale in the USA.
© Abingdon Health 2019